Literature DB >> 25920765

Cancer stem cells and field cancerization of oral squamous cell carcinoma.

M Simple1, Amritha Suresh2, Debashish Das3, Moni A Kuriakose4.   

Abstract

Oral squamous cell carcinoma (OSCC) has a high propensity for local failure, which is attributed to recurrence at the primary site or the development of second primary tumors (SPT). Field cancerization that refers to the existence of transformed cells in areas adjacent to the primary tumor, has been attributed to be one of the probable reasons underlying disease relapse. The carcinogenic process necessitates multiple molecular events for the transformation of a normal cell into a cancer cell. This implies that only the long-time residents of the epithelium, such as the stem cells, might be the candidates capable of accumulating these genetic hits. These transformed stem cells- the 'Cancer stem cells' (CSCs), are further known to be equipped with the properties of tumor initiation and migration, both of which are essential for orchestrating field cancerization. The concept that the CSCs might be responsible for field cancerization in OSCC has not been explored extensively. If the role of CSCs as the primary units of field cancerization process is established, their presence in the mucosa adjacent to the tumor may be an indicator for local recurrence and/or development of second primary tumors. In this review, we examine the available evidence in literature exploring the possibilities of CSCs driving the process of field cancerization and thereby being the underlying mechanism for disease recurrence and development of SPT. Published by Elsevier Ltd.

Entities:  

Keywords:  Cancer stem cells; Field cancerization; Loss of heterozygosity; Migration; Oral carcinogenesis; Oral squamous cell carcinoma; Recurrent tumor; Second primary tumor

Mesh:

Year:  2015        PMID: 25920765     DOI: 10.1016/j.oraloncology.2015.04.006

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  24 in total

Review 1.  Somatic mosaicism: on the road to cancer.

Authors:  Luis C Fernández; Miguel Torres; Francisco X Real
Journal:  Nat Rev Cancer       Date:  2015-12-18       Impact factor: 60.716

2.  The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa.

Authors:  Roman C Brands; Olga Köhler; Stephan Rauthe; Stefan Hartmann; Harald Ebhardt; Axel Seher; Christian Linz; Alexander C Kübler; Urs D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2016-09-08       Impact factor: 3.573

3.  Relationship between CD44high/CD133high/CD117high cancer stem cells phenotype and Cetuximab and Paclitaxel treatment response in head and neck cancer cell lines.

Authors:  Ana Livia Silva Galbiatti-Dias; Glaucia Maria Mendonça Fernandes; Marcia Maria Urbanin Castanhole-Nunes; Luiza Fernandes Hidalgo; Carlos Henrique Viesi Nascimento Filho; Rosa Sayoko Kawasaki-Oyama; Leticia Antunes Muniz Ferreira; Patricia Matos Biselli-Chicote; Érika Cristina Pavarino; Eny Maria Goloni-Bertollo
Journal:  Am J Cancer Res       Date:  2018-08-01       Impact factor: 6.166

4.  Cancer stem cell and its niche in malignant progression of oral potentially malignant disorders.

Authors:  Subin Surendran; Gangotri Siddappa; Amrutha Mohan; Wesley Hicks; Vijayvel Jayaprakash; Christina Mimikos; Mohammed Mahri; Fatima Almarzouki; Kayla Morrell; Ravindra Ravi; Sindhu Govindan; C N Sushma; Nisheena Raghavan; Praveen Birur; Jeyaram Ilayaraja; Mihai Merzianu; Mary Reid; Amritha Suresh; Moni Abraham Kuriakose
Journal:  Oral Oncol       Date:  2017-11-12       Impact factor: 5.337

5.  Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.

Authors:  Susan R Mallery; Daren Wang; Brian Santiago; Ping Pei; Caroline Bissonnette; Jayanetti Asiri Jayawardena; Steven P Schwendeman; Richard Spinney; James Lang
Journal:  Mol Cancer Ther       Date:  2019-09-12       Impact factor: 6.261

Review 6.  Trends in Surgical Research in Head and Neck Cancer.

Authors:  Genrich Tolstonog; Christian Simon
Journal:  Curr Treat Options Oncol       Date:  2017-06

7.  Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals.

Authors:  Ayelet Zlotogorski-Hurvitz; Dan Dayan; Gavriel Chaushu; Tuula Salo; Marilena Vered
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-27       Impact factor: 4.553

8.  Intra-operative point-of-procedure delineation of oral cancer margins using optical coherence tomography.

Authors:  Sumsum P Sunny; Sagar Agarwal; Bonney Lee James; Emon Heidari; Anjana Muralidharan; Vishal Yadav; Vijay Pillai; Vivek Shetty; Zhongping Chen; Naveen Hedne; Petra Wilder-Smith; Amritha Suresh; Moni Abraham Kuriakose
Journal:  Oral Oncol       Date:  2019-03-15       Impact factor: 5.337

9.  Follow-up of oral and oropharyngeal cancer using narrow-band imaging and high-definition television with rigid endoscope to obtain an early diagnosis of second primary tumors: a prospective study.

Authors:  Giancarlo Tirelli; Marco Piovesana; Pierluigi Bonini; Annalisa Gatto; Giuseppe Azzarello; Francesca Boscolo Nata
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-10       Impact factor: 2.503

Review 10.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.